Theravance Biopharma - Company & Market Research Reports

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Antibiotics: the Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts - Product Thumbnail Image

Antibiotics: the Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts

  • Report
  • 299 Pages
From
2018 Opioid Induced Constipation (OIC) Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Opioid Induced Constipation (OIC) Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
Global Peptide Antibiotics Market & Clinical Pipeline Insight 2023 - Product Thumbnail Image

Global Peptide Antibiotics Market & Clinical Pipeline Insight 2023

  • Drug Pipelines
  • 140 Pages
From
Pneumonia Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pneumonia Drug Development Pipeline Review, 2017

  • Report
  • 123 Pages
From
Global Antibiotics Market 2017-2021 - Product Thumbnail Image

Global Antibiotics Market 2017-2021

  • Report
  • 118 Pages
From
2018 Diabetic Gastroparesis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Diabetic Gastroparesis Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
2018 Chronic Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart Failure Market - Product Thumbnail Image

2018 Chronic Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart Failure Market

  • Report
  • 70 Pages
From
2018 Hypotension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Hypotension Market - Product Thumbnail Image

2018 Hypotension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Hypotension Market

  • Report
  • 70 Pages
From
2018 Acute Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Acute Heart Failure Market - Product Thumbnail Image

2018 Acute Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Acute Heart Failure Market

  • Report
  • 70 Pages
From
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018

  • Report
  • 390 Pages
From
Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026

  • Report
  • 49 Pages
From
Asthma: Pipeline Assessment and Insights - Product Thumbnail Image

Asthma: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Asthma: Market Intelligence Review and Insights - Product Thumbnail Image

Asthma: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Asthma: Epidemiology Overview and Insights - Product Thumbnail Image

Asthma: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta - Product Thumbnail Image

Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta

  • Report
From
Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations - Product Thumbnail Image

Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations

  • Report
  • 142 Pages
From
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026  - Product Thumbnail Image

Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026

  • Report
  • 266 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2018 to 2023 - Product Thumbnail Image

Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2018 to 2023

  • Report
  • 284 Pages
From
Antibiotic Resistance Markets - Pharmaceutical Therapeutics - By Pathogen and Therapy Type Strategies & Trends 2018 to 2023 - Product Thumbnail Image

Antibiotic Resistance Markets - Pharmaceutical Therapeutics - By Pathogen and Therapy Type Strategies & Trends 2018 to 2023

  • Report
  • 279 Pages
From
Loading Indicator
adroll